KPTI | KARYOPHARM THERAPEUTICS INC

CUSIP: 48576UAA4

0 Funds Holding
0 Total Shares
$0 Total Value
$6.64
Price
$122M
Market Cap
P/E Ratio
-1.3
Forward P/E
$-14.70
EPS (TTM)
Dividend Yield
$46M
Cash
$195M
Total Debt
18M
Shares Out
$3.51
$10.76
52-Week Range

Institutional Ownership of KARYOPHARM THERAPEUTICS INC

Fund / Manager Click to search
Shares Value % of Portfolio Cost Basis Est. Return
No funds currently hold this stock.

Trading Activity for KARYOPHARM THERAPEUTICS INC

Fund / Manager Click to search
Action Change Shares After Value Price
No activity found for this stock.

Insider Trading for KARYOPHARM THERAPEUTICS INC

6 Months Insider Sentiment
100%
Buy $0 Sell $19K
0 Buys
8 Sells
-19K Net
12 Grants
Largest
$8K Paulson
$3K Rangwala
$3K Poulton
Date
Insider Click to search
Role Click to search
Type Shares Price Value
Oct 15, 2025 Sohanya Roshan Cheng EVP & Chief Commercial Officer GRANT 43.6K
Oct 15, 2025 Michael Mano SVP, General Counsel&Secretary GRANT 43.6K
Oct 15, 2025 Richard A. Paulson President and CEO GRANT 114.3K
Oct 15, 2025 Stuart Poulton EVP, Chief Development Officer GRANT 39.7K
Oct 15, 2025 Kristin Abate Chief Accounting Officer GRANT 12.8K
Oct 15, 2025 Lori Macomber EVP, CFO & Treasurer GRANT 43.6K
Oct 01, 2025 Kristin Abate Chief Accounting Officer SELL 362 $6.30 $2K
Sep 15, 2025 Reshma Rangwala EVP & Chief Medical Officer SELL 408 $6.43 $3K
Sep 15, 2025 Kristin Abate Chief Accounting Officer SELL 23 $6.43 $148
Sep 15, 2025 Michael Mano SVP, General Counsel&Secretary SELL 234 $6.43 $2K
Sep 15, 2025 Richard A. Paulson President and CEO SELL 1.3K $6.43 $8K
Sep 15, 2025 Sohanya Roshan Cheng EVP & Chief Commercial Officer SELL 325 $6.43 $2K
Sep 15, 2025 Stuart Poulton EVP, Chief Development Officer SELL 401 $6.43 $3K
Sep 12, 2025 Michael Mano SVP, General Counsel&Secretary GRANT 612
Sep 12, 2025 Sohanya Roshan Cheng EVP & Chief Commercial Officer GRANT 945
Sep 12, 2025 Kristin Abate Chief Accounting Officer GRANT 46
Sep 12, 2025 Reshma Rangwala EVP & Chief Medical Officer GRANT 945
Sep 12, 2025 Stuart Poulton EVP, Chief Development Officer GRANT 888
Sep 12, 2025 Richard A. Paulson President and CEO GRANT 2.8K
Sep 03, 2025 Kristin Abate Chief Accounting Officer SELL 12 $6.78 $81